Literature DB >> 16097950

Specific conformational changes of plasminogen induced by chloride ions, 6-aminohexanoic acid and benzamidine, but not the overall openness of plasminogen regulate, production of biologically active angiostatins.

Debra J Warejcka1, Sally S Twining.   

Abstract

The overall conformation of plasminogen depends upon the presence of anions and molecules such as AHA (6-aminohexanoic acid) and BZ (benzamidine). The purpose of the present study was to determine the effect of conformation on the initial and secondary cleavages of plasminogen to generate active angiostatins. Plasminogen was digested with the physiologically relevant neutrophil elastase in one of the four Tris/acetate buffers: buffer alone or buffer plus NaCl, AHA or BZ. The initial cleavage of Glu1-plasminogen was much slower in the tight NaCl-induced alpha-conformation, fastest in the intermediate BZ-induced beta-conformation and intermediate both in the control and in the AHA-induced open gamma-conformation. Although the buffer system determined the relative amounts of the initial cleavage products, the same four cleavage sites were utilized under all conditions. A fifth major initial cleavage within the protease domain was observed in the presence of BZ. N-terminal peptide cleavage required for angiostatin formation occurred as either the initial or the secondary cleavage. Angiostatins were generated fastest in the presence of BZ and slowest in the presence of NaCl. Both the initial and secondary cleavages were affected by the modifying agents, indicating that they influence the conformation of both Glu-plasminogen and the initial cleavage products. The angiostatins produced under the different conditions inhibited proliferation of human umbilical-vein endothelial cells. These results suggest that plasminogen conversion into active angiostatins is dependent more on the specific conformation changes induced by the various modifying reagents rather than on the overall openness of the molecule.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097950      PMCID: PMC1316312          DOI: 10.1042/BJ20050907

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.

Authors:  Y Gong; S O Kim; J Felez; D K Grella; F J Castellino; L A Miles
Journal:  J Biol Chem       Date:  2001-03-22       Impact factor: 5.157

Review 2.  Plasminogen activator/plasmin system: a major player in wound healing?

Authors:  Wai-Yee Li; Sheree S N Chong; Eunice Y Huang; Tai-Lan Tuan
Journal:  Wound Repair Regen       Date:  2003 Jul-Aug       Impact factor: 3.617

3.  Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin.

Authors:  P Stathakis; A J Lay; M Fitzgerald; C Schlieker; L J Matthias; P J Hogg
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

4.  Design, synthesis, and in vitro activities of benzamide-core glycoprotein IIb/IIIa antagonists: 2,3-diaminopropionic acid derivatives as surrogates of aspartic acid.

Authors:  C B Xue; J Roderick; S Jackson; M Rafalski; A Rockwell; S Mousa; R E Olson; W F DeGrado
Journal:  Bioorg Med Chem       Date:  1997-04       Impact factor: 3.641

5.  Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells.

Authors:  W Morikawa; K Yamamoto; S Ishikawa; S Takemoto; M Ono; J i Fukushi; S Naito; C Nozaki; S Iwanaga; M Kuwano
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

6.  Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors.

Authors:  G Kassam; M Kwon; C S Yoon; K S Graham; M K Young; S Gluck; D M Waisman
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

7.  Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.

Authors:  Patrizia Scapini; Lorella Nesi; Monica Morini; Elena Tanghetti; Mirella Belleri; Douglas Noonan; Marco Presta; Adriana Albini; Marco A Cassatella
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

8.  Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen.

Authors:  Antonietta R Farina; Antonella Tacconelli; Lucia Cappabianca; Alberto Gulino; Andrew R Mackay
Journal:  Eur J Biochem       Date:  2002-09

9.  Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9).

Authors:  B C Patterson; Q A Sang
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

10.  Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.

Authors:  R Cao; H L Wu; N Veitonmäki; P Linden; J Farnebo; G Y Shi; Y Cao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

View more
  1 in total

1.  Residues essential for plasminogen binding by the cation-independent mannose 6-phosphate receptor.

Authors:  Richard N Bohnsack; Manish Patel; Linda J Olson; Sally S Twining; Nancy M Dahms
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.